AB France: Euronext Paris

    AB Science S.A.

    Last Updated: Oct 27, 2021 5:35 p.m. CEDT Delayed quote


    0.15 1.13%
    Previous Close
    Advanced Charting
    Volume: 68.01K 65 Day Avg: 120.47K
    56% vs Avg
    13.13 Day Range 13.76
    6.95 52 Week Range 21.75

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    AB Overview


    5 Day
    • 0.30%
    1 Month
    • 2.53%
    3 Month
    • -8.85%
    • -31.89%
    1 Year
    • 50.45%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    No Headlines Available

    No Headlines Available

    AB Science S.A.

    AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.


    Name Chg % Market Cap
    Genfit S.A. -2.33% €145.13M
    IntegraGen S.A. 0.00% €8.27M
    Virbac S.A. 2.30% €3.48B
    Nanobiotix -6.08% €354.72M
    Hybrigenics S.A. -1.36% €51.99M
    Neovacs S.A. -10.00% €7.09M
    Quantum Genomics S.A.S. -2.29%
    Qiagen N.V. -1.82% €10.82B
    Vetoquinol -1.49% €1.75B
    Competitor Data Provided ByCapital Cube Logo